5292-48-8 Usage
Common Uses
Synthesis of pharmaceuticals
Synthesis of agrochemicals
Synthesis of dyes
Plasticizer in the production of polyvinyl chloride (PVC) and other polymers
Toxicity
Toxic to aquatic organisms
Environmental Impact
May cause long-term adverse effects in the aquatic environment
Handling and Disposal
Should be handled and disposed of with care to prevent harm to human health and the environment
Chemical Structure
Ester derivative of 1,4-Benzenedicarboxylic acid with a fluorine atom at the 2nd position and a nitro group at the 5th position, and two methyl groups attached to the carboxylic acid groups
Physical State
Likely a solid at room temperature, though exact physical properties are not provided
Molecular Weight
Not provided, but can be calculated from the molecular formula
Appearance
Not provided, but may be a yellow or colorless solid based on similar compounds
Solubility
Not provided, but likely soluble in organic solvents like ethanol or acetone
Stability
Not provided, but may be sensitive to heat, light, or moisture based on the presence of a nitro group
Reactivity
Not provided, but the nitro group may be reactive with reducing agents or bases
Regulatory Status
Not provided, but may be subject to environmental or workplace safety regulations due to its toxicity and potential environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 5292-48-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,9 and 2 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5292-48:
(6*5)+(5*2)+(4*9)+(3*2)+(2*4)+(1*8)=98
98 % 10 = 8
So 5292-48-8 is a valid CAS Registry Number.
5292-48-8Relevant articles and documents
PROLYL HYDROXYLASE INHIBITORS
-
Page/Page column 23-24, (2010/07/10)
The invention described herein relates to certain 2,4-dioxo-l,2,3,4-tetrahydro-7- quinazolinecarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
